+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

AB0574Evaluation of the efficacy of tocilizumab toward the patients with active rheumatoid arthritis of nagasaki prefecture, japan



AB0574Evaluation of the efficacy of tocilizumab toward the patients with active rheumatoid arthritis of nagasaki prefecture, japan



Annals of the Rheumatic Diseases 71(Suppl 3): 671.6-671




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 064274879

Download citation: RISBibTeXText

DOI: 10.1136/annrheumdis-2012-eular.574


Related references

The efficacy and safety of reinstitution of tocilizumab in patients with relapsed active rheumatoid arthritis after long-term withdrawal of tocilizumab: retreatment of patients with rheumatoid arthritis with novel anti-IL-6 receptor antibody after a long-term interval following SAMURAI: the RONIN study. Modern Rheumatology 21(4): 352-358, 2011

The efficacy and safety of reinstitution of tocilizumab in patients with relapsed active rheumatoid arthritis after long-term withdrawal of tocilizumab. Modern Rheumatology 21(4): 352-358, 2011

Evaluation of safety, efficacy and post-cessation efficacy durability of tocilizumab in patients with active rheumatoid arthritis. International Journal of Rheumatic Diseases 20(2): 231-237, 2017

Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis. Korean Journal of Internal Medicine 34(4): 917-931, 2019

Two-year efficacy of tocilizumab in patients with active rheumatoid arthritis in clinical practice. Reumatologia Clinica 13(2): 78-84, 2016

Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study. Clinical and Experimental Rheumatology 37(3): 437-444, 2018

Clinical evaluation of tocilizumab for patients with active rheumatoid arthritis refractory to anti-Tnf biologics: tocilizumab in combination with methotrexate. Modern Rheumatology 20(4): 343-352, 2010

Clinical evaluation of tocilizumab for patients with active rheumatoid arthritis refractory to anti-TNF biologics: tocilizumab in combination with methotrexate. Modern Rheumatology 20(4): 343-352, 2010

Clinical efficacy of tocilizumab in patients with active rheumatoid arthritis in real clinical practice. Rheumatology International 30(8): 1041-1048, 2010

Comparison of the efficacy and tolerability of tocilizumab, sarilumab, and sirukumab in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials. Clinical Rheumatology 37(6): 1471-1479, 2018

Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study. Annals of the Rheumatic Diseases 71(2): 198-205, 2012

Efficacy and safety of tocilizumab in monotherapy, an anti-IL-6 receptor monoclonal antibody, in patients with active rheumatoid arthritis: Results from a 24 week double-blind phase III study. 2006

Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (Reaction study). Modern Rheumatology 21(2): 122-133, 2011

Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study). Modern Rheumatology 21(2): 122-133, 2011

Concurrent Oral 1 - Rheumatoid Arthritis: Treatment [Op4-Op9]: Op4. Inhibition of Radiographic Progression and Improvements in Physical Function at 2 Years, with Increasing Clinical Efficacy Over Time, in Rheumatoid Arthritis (Ra) Patients Treated with Tocilizumab (Tcz): The Lithe Study. Rheumatology 49(Suppl. 1): i3-i5, 2010